$Genprex (GNPX.US)$ This groundbreaking research represents a significant advancement in addressing one of oncology's most challenging problems: resistance to immunotherapy in non-small cell lung cancer. The study's findings are particularly compelling for several reasons: The demonstrated efficacy of NPRL2 gene therapy in anti-PD1 resistant cases is remarkable, especially considering that pembrolizumab (Keytruda®), a leading immunotherapy generating over 20 billion in ...
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Genprex Stock Forum
This groundbreaking research represents a significant advancement in addressing one of oncology's most challenging problems: resistance to immunotherapy in non-small cell lung cancer. The study's findings are particularly compelling for several reasons:
The demonstrated efficacy of NPRL2 gene therapy in anti-PD1 resistant cases is remarkable, especially considering that pembrolizumab (Keytruda®), a leading immunotherapy generating over 20 billion in ...
Major Cancer Treatment Breakthrough: New Gene Therapy Defeats Drug-Resistant Lung Cancer
No comment yet